Home/Filings/4/0001485003-22-000018
4//SEC Filing

MacDonald Glen C 4

Accession 0001485003-22-000018

CIK 0001485003other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 8:33 PM ET

Size

5.1 KB

Accession

0001485003-22-000018

Insider Transaction Report

Form 4
Period: 2022-02-18
MacDonald Glen C
Chief Technology Officer
Transactions
  • Award

    Common Stock

    2022-02-18+308,925308,925 total
Footnotes (1)
  • [F1]Represents restricted stock units ("RSUs") which shall vest annually in equal amounts over a four-year period following the grant date, so long as the reporting person remains employed by Sesen Bio, Inc. (the "Company"). Each RSU represents a contingent right to receive one share of the Company's common stock. The compensation committee of the Company approved the grant to the reporting person, based on market analysis by Radford of public, pre-commercial and commercial biopharmaceutical companies.

Issuer

Sesen Bio, Inc.

CIK 0001485003

Entity typeother

Related Parties

1
  • filerCIK 0001773277

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:33 PM ET
Size
5.1 KB